سعر رايت-إيس 5 مجم أقراص 2026

Ramipril 5 mg oral tablets (ACE inhibitor), pack of 30, marketed in Egypt by Adwia.

• Treatment of hypertensionPopulation: Adultselectronic medicines compendium (emc)
• Cardiovascular prevention: reduction of cardiovascular morbidity and mortality in patients with manifest atherothrombotic cardiovascular disease or diabetes with at least one cardiovascular risk factorPopulation: Adultselectronic medicines compendium (emc)
• Treatment of renal disease (incipient or manifest diabetic glomerular nephropathy; manifest non-diabetic glomerular nephropathy)Population: Adultselectronic medicines compendium (emc)

• Most common adverse reactions in hypertension trials: headache, dizziness, fatigue and cough.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Common: headache, dizziness and increased blood potassium (among others listed in the SmPC frequency table).International label, same formulation · electronic medicines compendium (emc)

• Hypersensitivity to ramipril, any excipient or any other ACE inhibitor.International label, same formulation · electronic medicines compendium (emc)
• History of angioedema (hereditary, idiopathic or due to previous ACE inhibitor or AIIRA angioedema).International label, same formulation · electronic medicines compendium (emc)
• Significant bilateral renal artery stenosis or renal artery stenosis in a single functioning kidney; hypotensive or haemodynamically unstable states; extracorporeal treatments bringing blood into contact with negatively charged surfaces.International label, same formulation · electronic medicines compendium (emc)

• Boxed warning: fetal toxicity. Drugs acting directly on the renin-angiotensin system can cause injury and death to the developing fetus; discontinue as soon as pregnancy is detected.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Angioedema (including intestinal angioedema) and anaphylactoid reactions may occur at any time during ACE inhibitor treatment.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Symptomatic hypotension, most likely in volume- or salt-depleted patients (e.g. on prolonged diuretic therapy).General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• DiureticsExcessive blood pressure reduction may occur after starting ramipril in patients on diuretics.DailyMed (U.S. National Library of Medicine)
• Potassium-raising agents (potassium supplements, potassium-sparing diuretics)May cause hyperkalaemia; monitor serum potassium.DailyMed (U.S. National Library of Medicine)
• LithiumIncreased serum lithium and lithium toxicity reported; monitor lithium levels.DailyMed (U.S. National Library of Medicine)

• Use of renin-angiotensin system drugs in the second and third trimesters reduces fetal renal function and increases fetal and neonatal morbidity and death; discontinue as soon as pregnancy is detected.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Ramipril: Prodrug hydrolysed to ramiprilat, which inhibits angiotensin-converting enzyme, reducing angiotensin II formation and aldosterone secretion.